药品评价
藥品評價
약품평개
DRUG REEVALUATION
2013年
14期
30-33
,共4页
抗菌药物%预防%围手术期%合理用药
抗菌藥物%預防%圍手術期%閤理用藥
항균약물%예방%위수술기%합리용약
Antibiotics%Preventive%Perioperative%Rational Drug Use
目的：评价我院围手术期预防应用抗菌药物情况，促进临床合理用药。方法：对我院2012年7-9月份所抽查的145例患者抗菌药物专项点评资料进行回顾性分析，从抗菌药物的品种选择、用药时机、用药疗程、联合用药等指标进行分类统计。结果：所抽查145病例中抗菌药物使用率为79.3%，Ⅰ类切口手术抗菌药物使用率为72.5%，术前0.5h~2h用药病例为57例，术前2h用药病例为7例，术后用药病例为51例；预防用药疗程≤1d的有2例；≤2d的21例；3~7d的64例；＞7d的8例。Ⅰ类切口和Ⅱ类切口的平均用药天数分别为4.2d和5.6d。结论：我院围手术期抗菌药物的使用仍存在不合理之处，应加强管理，规范用药。
目的：評價我院圍手術期預防應用抗菌藥物情況，促進臨床閤理用藥。方法：對我院2012年7-9月份所抽查的145例患者抗菌藥物專項點評資料進行迴顧性分析，從抗菌藥物的品種選擇、用藥時機、用藥療程、聯閤用藥等指標進行分類統計。結果：所抽查145病例中抗菌藥物使用率為79.3%，Ⅰ類切口手術抗菌藥物使用率為72.5%，術前0.5h~2h用藥病例為57例，術前2h用藥病例為7例，術後用藥病例為51例；預防用藥療程≤1d的有2例；≤2d的21例；3~7d的64例；＞7d的8例。Ⅰ類切口和Ⅱ類切口的平均用藥天數分彆為4.2d和5.6d。結論：我院圍手術期抗菌藥物的使用仍存在不閤理之處，應加彊管理，規範用藥。
목적：평개아원위수술기예방응용항균약물정황，촉진림상합리용약。방법：대아원2012년7-9월빈소추사적145례환자항균약물전항점평자료진행회고성분석，종항균약물적품충선택、용약시궤、용약료정、연합용약등지표진행분류통계。결과：소추사145병례중항균약물사용솔위79.3%，Ⅰ류절구수술항균약물사용솔위72.5%，술전0.5h~2h용약병례위57례，술전2h용약병례위7례，술후용약병례위51례；예방용약료정≤1d적유2례；≤2d적21례；3~7d적64례；＞7d적8례。Ⅰ류절구화Ⅱ류절구적평균용약천수분별위4.2d화5.6d。결론：아원위수술기항균약물적사용잉존재불합리지처，응가강관리，규범용약。
Objective: To evaluate the perioperative antibiotic prophylaxis in our hospital to promote rational antibiotic use. Method: Totally 145 operative cases from July to September in 2012 were included. Data of perioperative antibiotic prophylactic use on drug categories, administration timing, duration of treatment and combined medication were collected and analyzed retrospectively. Results: The rate of antibiotic prophylaxis was 79.3% for all operative cases and 72.5% for class I operation, respectively. Antibiotics were administrated 0.5h-2h before oparation in 57 cases, 2h before surgery in 7 cases and postoperatively in 51 cases. The duration of prophylaxis is less than 1d in 2 cases, less than 2d in 21 cases, 3-7d in 64 cases and more than 7d in 8 cases. The average days of medication for class I incision and class II incison were 4.2d and 5.6d respectively. Conclusion:There is still unreasonableness in the perioperative antibiotic prophylaxis in our hospital. We should standardize the usage and management of antibiotics.
